Ultra Market Research | UK Bariatric Surgery Devices Market
UK Bariatric Surgery Devices Market
Report ID : 988
Category : Medical-Devices,United-Kingdom(UK)
No Of Pages : 135
Published on: February 2025
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Introduction
The UK Bariatric Surgery Devices Market is a segment of medical equipment designed to assist in weight-loss surgeries, such as gastric bypass, sleeve gastrectomy, and laparoscopic adjustable gastric banding. These devices are crucial in treating severe obesity and related health conditions like type 2 diabetes, hypertension, and sleep apnea. As obesity levels continue to grow in the UK, there has been a strong demand for bariatric surgery devices, and this has triggered innovation in minimally invasive surgical tools and technologies. The market is valued at around GBP 1 billion as of 2023 and is growing healthily. Recent trends indicate the advancements in robotic-assisted surgery and improved patient outcomes, further driving market expansion. As the healthcare system focuses on more effective obesity management, the UK Bariatric Surgery Devices Market is shifting towards more personalized and efficient surgical solutions. The current scenario highlights continuous growth driven by technological improvements and increased patient awareness.
Segmentation
Segment 1: Type of Devices
Surgical Instruments
Staplers Scalpels Others Implantable Devices
Gastric Bands Intragastric Balloons Robotic Surgery Devices
Robotic-Assisted Surgical Tools Laparoscopic Robotic Systems Endoscopic Devices
Medtronic (Ireland) Johnson & Johnson (USA) Intuitive Surgical (USA) Stryker Corporation (USA) Abbott Laboratories (USA) Boston Scientific (USA) Ethicon (USA) Zimmer Biomet (USA) Apollo Endosurgery (USA) EndoChoice (USA) Cook Medical (USA) Conmed Corporation (USA) Olympus Corporation (Japan) B. Braun Melsungen AG (Germany) Karl Storz GmbH & Co. KG (Germany)
Drivers
Several key factors are driving the UK Bariatric Surgery Devices Market forward. The rising incidence of obesity is a major driver, with more individuals suffering from weight-related health issues such as type 2 diabetes, hypertension, and sleep apnea. The effectiveness of bariatric surgery in addressing these comorbidities has made it a favored treatment choice. In addition, advancements in surgical technologies, such as robotic-assisted surgeries and minimally invasive techniques, have significantly improved patient outcomes and recovery times. As the healthcare system adapts to address the growing obesity epidemic, public awareness campaigns have increased, encouraging more individuals to seek bariatric surgeries. Additionally, the availability of comprehensive insurance coverage and government-funded healthcare options in the UK is helping patients access these treatments. The continual innovation in surgical tools, such as gastric bands and endoscopic devices, also supports market growth by offering more precise, less invasive, and more effective solutions for bariatric procedures.
Restraints
Despite the healthy growth of the UK Bariatric Surgery Devices Market, several challenges face the industry. A strong restraint in this industry is that bariatric surgeries and devices are costly; this could severely limit the patient's ability to afford even if he or she has insurance. It requires many additional follow-ups after surgery for proper recovery and further care. The government also covers some bariatric treatments, but the eligibility criteria are very strict, and this leads to long waiting times for patients. There is also a stigma attached to weight-loss surgery, which may discourage some people from opting for it. Another challenge is the possibility of complications during and after surgery, including infections, bleeding, and nutritional deficiencies, which may lead to less favorable outcomes and higher costs for healthcare providers. Lastly, regulatory hurdles, such as the need for extensive clinical trials and approval processes for new devices, can delay the introduction of innovative products into the market.
Opportunity
The UK Bariatric Surgery Devices Market is wide open for future growth as many of the advancements have recently increased interest in less invasive surgical practices. Robotic surgeries are especially increasing because, through their exactitude and improved recovery, surgeons and patients welcome this trend, providing significant space for the availability of newer sophisticated yet economical variants of the respective devices. Additionally, with obesity rates on the rise and the increasing awareness surrounding the health risks associated with it, more patients are opting for bariatric surgeries. This creates an opportunity for market players to develop new, innovative products that cater to patient needs, such as personalized surgical instruments and devices that provide better patient outcomes. There is also an emerging trend of offering integrated post-surgical care through advanced monitoring systems, which further supports market growth. Furthermore, as public health campaigns and insurance policies increasingly support bariatric surgery, the demand for these devices is likely to expand.
Trend
A huge trend in the UK Bariatric Surgery Devices Market is the trend towards robotic-assisted and minimal access technologies for bariatric surgery. The devices are changing the game by shortening recovery times, minimizing surgical complications, and overall improving patient outcomes. This technology refers to the even more precise procedures and smaller incisions that guarantee less post-operative pain and faster return to normal activities. In addition to this, there is a shift toward using non-invasive methods, such as endoscopic devices and intragastric balloons, for weight-loss treatments. These approaches provide an alternative to traditional surgery, with fewer risks and shorter recovery periods. As healthcare providers continue to focus on improving the patient experience, the market is also seeing increased adoption of personalized care technologies, including tailored surgical plans and advanced monitoring systems to track patient progress post-surgery. This trend is expected to continue driving market growth in the coming years.
Endoscopic Sleeve Gastroplasty (ESG) Lap-Band Adjustable Gastric Banding System ReShape Integrated Dual Balloon System Medtronic Hugo™ Robotic-Assisted Surgery System Apollo OverStitch Endoscopic Suturing System TransPyloric Shuttle Device
Key Target Audience
Healthcare Providers (Hospitals, Clinics, Surgical Centers) Bariatric Surgeons and Surgeons’ Associations Medical Device Manufacturers and Distributors Regulatory Bodies and Policy Makers Insurance Providers and Health Insurers Obesity and Weight Loss Centers Research and Academic Institutions
The UK Bariatric Surgery Devices Market is valued at approximately GBP 1 billion in 2023 and is projected to grow steadily in the coming years.
The key drivers include rising obesity rates, advancements in minimally invasive surgery technologies, and increased patient awareness of bariatric procedures.
High costs of surgery, long waiting times, and potential surgical complications are the primary challenges facing the market.
The shift towards robotic-assisted and minimally invasive surgery, along with personalized surgical care, is a prominent trend in the market.
Key players include Medtronic, Johnson & Johnson, Intuitive Surgical, Stryker Corporation, and Abbott Laboratories, among others.
1.Introduction 1.1 Report Description 1.2 Research Methodology 1.2.1 Data Mining 1.2.2 Market Modeling and Forecasting 1.2.3 Data Validation 1.2.4 Industry Analysis
2.Market Dashboard
3.Market Overview 3.1 Market Definition and Scope 3.2 Market Segmentation 3.2.1 By Treatment Types 3.2.1.1 Chemotherapy 3.2.1.1.1 Induction Phase 3.2.1.1.2 Consolidation Phase 3.2.1.1.3 Maintenance Phase 3.2.1.2 Targeted Therapies 3.2.1.2.1 Tyrosine Kinase Inhibitors 3.2.1.2.2 Antibody-Drug Conjugates 3.2.1.2.3 Others 3.2.1.3 Immunotherapies 3.2.1.3.1 CAR-T Therapy 3.2.1.3.2 Monoclonal Antibodies 3.2.2 By Patient Demographics 3.2.2.1 Children 3.2.2.1.1 Infants 3.2.2.1.2 Toddlers and Young Children 3.2.2.2 Adults 3.2.2.2.1 Young Adults 3.2.2.2.2 Seniors 3.2.3 By Distribution Channels 3.2.3.1 Hospital Pharmacies 3.2.3.1.1 Tertiary Care Centers 3.2.3.1.2 Pediatric Oncology Units 3.2.3.2 Retail Pharmacies 3.2.3.2.1 Local Pharmacies 3.2.3.2.2 Chain Pharmacies 3.2.3.3 Online Pharmacies 3.2.4 By Therapeutic Applications 3.2.4.1 First-Line Treatment 3.2.4.1.1 Chemotherapy-Only Regimens 3.2.4.1.2 Targeted Therapies 3.2.4.2 Relapse or Refractory ALL 3.2.4.2.1 CAR-T Therapies 3.2.4.2.2 Experimental Treatments
5.UK Bariatric Surgery Devices Market by Patient Demographics 5.1 Introduction 5.2 Market Size and Growth Rate by Patient Demographics (2024-2030) 5.2.1 Children 5.2.1.1 Infants 5.2.1.2 Toddlers and Young Children 5.2.2 Adults 5.2.2.1 Young Adults 5.2.2.2 Seniors
6.UK Bariatric Surgery Devices Market by Distribution Channels 6.1 Introduction 6.2 Market Size and Growth Rate by Distribution Channels (2024-2030) 6.2.1 Hospital Pharmacies 6.2.1.1 Tertiary Care Centers 6.2.1.2 Pediatric Oncology Units 6.2.2 Retail Pharmacies 6.2.2.1 Local Pharmacies 6.2.2.2 Chain Pharmacies 6.2.3 Online Pharmacies
7.UK Bariatric Surgery Devices Market by Therapeutic Applications 7.1 Introduction 7.2 Market Size and Growth Rate by Therapeutic Applications (2024-2030) 7.2.1 First-Line Treatment 7.2.1.1 Chemotherapy-Only Regimens 7.2.1.2 Targeted Therapies 7.2.2 Relapse or Refractory ALL 7.2.2.1 CAR-T Therapies 7.2.2.2 Experimental Treatments
10.Appendix 10.1 List of Tables Table UK Bariatric Surgery Devices Market Size by Treatment Types (2024-2030) Table Chemotherapy Market Size by Sub-type (2024-2030) Table Targeted Therapies Market Size by Sub-type (2024-2030) Table Immunotherapies Market Size by Sub-type (2024-2030) Table UK Bariatric Surgery Devices Market Size by Patient Demographics (2024-2030) Table Children Market Size by Sub-type (2024-2030) Table Adults Market Size by Sub-type (2024-2030) Table UK Bariatric Surgery Devices Market Size by Distribution Channels (2024-2030) Table Hospital Pharmacies Market Size by Sub-type (2024-2030) Table Retail Pharmacies Market Size by Sub-type (2024-2030) Table UK Bariatric Surgery Devices Market Size by Therapeutic Applications (2024-2030) Table First-Line Treatment Market Size by Sub-type (2024-2030) Table Relapse or Refractory ALL Market Size by Sub-type (2024-2030)
10.2 List of Figures Figure UK Bariatric Surgery Devices Market Size and Growth Rate by Treatment Types (2024-2030) Figure Chemotherapy Market Growth Rate by Sub-type (2024-2030) Figure Targeted Therapies Market Growth Rate by Sub-type (2024-2030) Figure Immunotherapies Market Growth Rate by Sub-type (2024-2030) Figure UK Bariatric Surgery Devices Market Size and Growth Rate by Patient Demographics (2024-2030) Figure Children Market Growth Rate by Sub-type (2024-2030) Figure Adults Market Growth Rate by Sub-type (2024-2030) Figure UK Bariatric Surgery Devices Market Size and Growth Rate by Distribution Channels (2024-2030) Figure Hospital Pharmacies Market Growth Rate by Sub-type (2024-2030) Figure Retail Pharmacies Market Growth Rate by Sub-type (2024-2030) Figure UK Bariatric Surgery Devices Market Size and Growth Rate by Therapeutic Applications (2024-2030)
11.Tables Financial Overview of Key Companies Table Amgen Inc. Bariatric Surgery Devices Financial Overview Table Novartis AG Bariatric Surgery Devices Financial Overview Table Pfizer Inc. Bariatric Surgery Devices Financial Overview Table Gilead Sciences Bariatric Surgery Devices Financial Overview Table Kite Pharma Bariatric Surgery Devices Financial Overview Table Takeda Pharmaceutical Company Bariatric Surgery Devices Financial Overview Table Bristol-Myers Squibb Bariatric Surgery Devices Financial Overview Table Jazz Pharmaceuticals Bariatric Surgery Devices Financial Overview Table AbbVie Inc. Bariatric Surgery Devices Financial Overview Table Sanofi Bariatric Surgery Devices Financial Overview Table Autolus Therapeutics Bariatric Surgery Devices Financial Overview Table Cellectis Bariatric Surgery Devices Financial Overview Table Allogene Therapeutics Bariatric Surgery Devices Financial Overview Table Celgene Corporation Bariatric Surgery Devices Financial Overview Table Eli Lilly and Company Bariatric Surgery Devices Financial Overview
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done, and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of United Kingdom market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices ofUK Bariatric Surgery Devices Marketand its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size ofUK Bariatric Surgery Devices Marketfor the past year and forecasts for the next six years.UK Bariatric Surgery Devices Marketsize is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of differentUK Bariatric Surgery Devices Marketcategories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand forUK Bariatric Surgery Devices Marketfrom different application industries in different regions.
Segmentation
Segment 1: Type of Devices
Surgical Instruments
Staplers Scalpels Others Implantable Devices
Gastric Bands Intragastric Balloons Robotic Surgery Devices
Robotic-Assisted Surgical Tools Laparoscopic Robotic Systems Endoscopic Devices
